NLRC3 Is a Potential Prognostic Biomarker That Is Correlated with Immune Cell Infiltration in Lung Adenocarcinoma

Researchers analyzed both RNA sequencing data and corresponding clinical outcomes obtained from public databases to identify (i) NLR family CARD domain containing 3 (NLRC3) gene as a tumor suppressor in lung adenocarcinoma (LUAD) and (ii) its predictive value for the likelihood of patient responsiveness to immunotherapy.